Barcelona-based epigenetics expert Oryzon Genomics has closed a debt funding round of €10.5m, bringing the...
Up To Date
Latest News
Ipsen is strengthening its ties to long-time development partner Oncodesign, a Dijon-based cancer treatment...
Swiss bank Group UBS has raised US$471m (€412m) for the UBS Oncology Impact Fund, which was set up to invest...
More revenue, more jobs, more financing, more R&D expenditure – all signs point towards sustainable growth in...
An expert panel’s final report on the fatal drug trial earlier this year in France states that the death of...
For up to US$685m (€606m), Dutch ArgenX has outlicensed its human antibody programme ARGX-115 to AbbVie. The...
Share
